C19orf62_5430437P03Rik Activators

C19orf62 can engage in various biochemical interactions to enhance the activity of this deubiquitinating enzyme. MLN4924, also known as Pevonedistat, inhibits the NEDD8-activating enzyme, leading to the accumulation of polyubiquitinated proteins. This accumulation can increase the substrate availability for C19orf62, thereby enhancing its activity as the enzyme works to counterbalance the heightened ubiquitin load. Similarly, Ubiquitin Vinyl Methyl Ester, a known deubiquitinase inhibitor, can cause an upsurge in the functional demand for C19orf62 by increasing the pool of ubiquitinated proteins that require processing, as the inhibition of other deubiquitinases can redirect substrate flow towards C19orf62.

Inhibition of specific ubiquitin-specific proteases (USPs) by compounds such as IU1, which targets USP14, and HBX 19818, which targets USP7, can lead to an indirect activation of C19orf62. By reducing the deubiquitinating activity of these USPs, the cellular system can depend more on C19orf62 to maintain the balance of ubiquitination and deubiquitination processes. LDN-57444's inhibition of UCHL1 can similarly lead to a compensatory increase in C19orf62 activity due to the greater availability of substrates that require deubiquitination. PR-619's broad-spectrum inhibition of deubiquitinases can stimulate C19orf62 to take on an elevated role in preserving protein homeostasis, as the enzyme works to mitigate the effects of widespread DUB inhibition. The compound b-AP15 targets the proteasome-associated deubiquitinases USP14 and UCHL5, and the subsequent reduction in their activity can necessitate a greater contribution from C19orf62 in the deubiquitination of proteins marked for degradation. Other selective inhibitors, such as GNE-6640 and WP1130, can also prompt an increase in C19orf62 activity by specifically diminishing the function of USP7 and multiple DUBs, respectively, thereby ensuring the vital process of deubiquitination continues efficiently within the cell.